Infectious

Latest Innovations

Novel Toll-Like Receptor Inhibitors for Treatment of Inflammatory Disease

Dr. Katzenellenbogen from the University of Illinois at Urbana-Champaign has developed a novel class of inhibitors capable of inhibiting Toll-like Receptor signaling....

HIV-1 Vaccine Immunogens

Dr. Procko from the University of Illinois at Urbana-Champaign has developed a novel set of HIV-1 immunogens for use as a HIV-1 vaccine. If effective these immunogens will...

Novel Toll-like Receptor Inhibitors for the Treatment of Inflammatory Diseases

Toll-like receptors (TLRs) have been shown to play a vital role in the pathogenesis of many diseases, including inflammatory diseases. Exaggerated or prolonged TLR...

Converting Gram-Positive Antibiotics to Gram-Negative Bacteria

Dr. Hergenrother from the University of IL has developed a method to convert compounds of Gram-positive antibiotics to Gram-negative antibiotics. This method and...

Rapid detection of intact viruses

Professor Yi Lu from the University of Illinois has developed an aptamer-based method for virus detection that is able to distinguish infective viruses from non-infective...

Rapid detection of target DNA using gFET and LAMP

Researchers from the University of Illinois have developed a highly sensitive, graphene field effect transistor (gFET) that can detect DNA in samples. This technology uses...

Activate Capture + Digital Counting (AC+DC) for ultrasensitive label-free detection of miRNA

Professor Brian Cunningham's research group at the University of Illinois has created a technology for ultrasensitive detection of gold nanoparticles, allowing different...

SPOT (Rapid, Accurate, Scalable and Portable Testing) for COVID-Diagnosis

Researchers from the University of Illinois have developed a COVID-19 testing system named SPOT that consists of a rapid, highly sensitive and accurate assay and a battery...

A Multivalent Cholera Multiepitope Fusion Antigen (MEFA) and Application for Development of Effective Vaccines for Cholera

 

Dr. Zhang from the University of Illinois has developed a promising candidate protein for a vaccine against cholera. Cholera is an acute, diarrheal illness caused...

Chimeric Secretory IgA

Professor Beth Stadtmueller and Sonya Kumar Bharathkar have created a chimeric secretory immunoglobulin A (cSIgA) with a modified secretory component (SC) that can be used...

Pages